Monday May 21 | Medical Daily
Newly Approved Generic Blood Thinner Saves Costs
The FDA recently approved the first ever generic version of the blood thinner Plavix.
Monday May 21 | Business Wire
Research and Markets: Peptic Ulcer Therapeutics - Pipeline Assessment and Market Forecasts to 2018
GlobalData estimates that the global peptic ulcer therapeutics market was worth $892.4m in 2010, and is forecast to grow at a Compound Annual Growth Rate of 2% to $1,046.2m by 2018.
Generic Versions Of Blood Thinning Plavix Approved By FDA
Generic versions of blood-thinning medication - Plavix - have been approved by the FDA .
FDA approves generic versions of antiplatelet drug
The U.S. Food and Drug Administration has approved generic versions of the blood thinning drug Plavix , which helps reduce the risk of myocardial infarction and stroke.
FDA Watch List: Proton Pump Inhibitors
The Food and Drug Administration released its most recent list of drugs that consumers and health professionals should keep their eye on due to serious risks or new safety information.
Also on Topix